Clinical Trials Logo

Hemostatic clinical trials

View clinical trials related to Hemostatic.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05733585 Recruiting - Hemostatic Clinical Trials

Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Start date: February 15, 2023
Phase:
Study type: Observational

Purabond Study is a physician-initiated, observational, monocentric prospective Trial. The aim of the study is to investigate the hemostatic efficacy of PuraBond for aortic anastomoses and suture lines in patients with abdominal aortic pathology (aneurysmal or steno occlusive disease) candidate to open repair at Vascular Surgery Departement - San Raffaele Hospital (Milan, Italy). The Study will include 100 patients.